Valneva SE (VALN)
8.88
+0.26
(+3.02%)
USD |
NASDAQ |
Dec 10, 16:00
8.87
-0.01
(-0.11%)
Pre-Market: 20:00
Valneva Total Liabilities (Quarterly): 349.86M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 57.64M |
| Cellectis SA | 242.57M |
| Innate Pharma SA | -- |
| Inventiva SA | -- |
| Nanobiotix SA | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 526.67M |
| Shareholders Equity (Quarterly) | 176.81M |
| Debt to Equity Ratio | 1.302 |
| Current Ratio | 1.783 |
| Net Debt Paydown Yield | -0.10% |